Life Sciences

Views & Analysis

LSX Inv€$tival Showcase round-up

On 14th November, investors and life science & healthcare executives descended on London’s famed Old Billingsgate building to attend LSX’s Inv€$tival Showcase, part of Europe’s biggest

Views & Analysis

Spotlight on women in pharma: Şeyda Atadan Memiş, Takeda

As part of our Women in Pharma series, where we talk to leading figures in the life sciences, we hear from Şeyda Atadan Memiş, recently appointed general manager for Takeda UK and

Views & Analysis

At ESMO 2022, oncologists saw exciting cancer advances

Lung, breast, and non-prostate genitourinary (NGU) cancer treatments were the most exciting tracks due to the march towards personalised medicine and expanded immunotherapy options.

Patients

Live from Reuters Pharma 2022 - the pharmaphorum podcast

In mid-October, our Web Editor Nicole Raleigh and Deep Dive Editor Eloise McLennan travelled to Nice for the Reuters Pharma event.

News

group of chemical scientists working at the laboratory.

BMA responds to ABPI report, warns UK losing research leader...

In response to the recent Association of British Pharmaceutical Industry (ABPI) report, which showed a sharp decline (41%) in clinical trials initiated by the UK in the period 2017 to 2021,

Views & Analysis